BPC 157 Banned: Key Facts on the Latest FDA Decision Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH Are Peptides Safe? Benefits, Risks & What Science Says BPC 157 Ligament: 1 Unsafe Truth